Healthcare

The company will acquire Solaris Health, a urology management services organization, for around $1.9 billion in cash.

Dr. Vinay Prasad, leader of the FDA division responsible for approving vaccines, is returning to the agency less than two weeks after leaving.

Despite trading at record highs, the S&P 500 can continue to climb on earnings and productivity, argues Adam Parker of Trivariate Research.

Shares of the life-sciences company have plummeted due in part to reduced demand amid Trump administration cuts.

Shares of the biotech company have gone nowhere since 2015. That may be about to change.

Yeti shares soared after our 2019 bullish article, then backtracked. New products can keep the company on Wall Street’s radar.

Amid the questions about the Yeztugo rollout, Gilead’s second quarter performance offered some reassurance about the company’s broader business.

Every corner of the sector is feeling the pain tis year. It’s well-positioned for a turnaround.

The drugmaker released its second-quarter earnings report early Wednesday as it vowed to cut costs amid intensifying competition and a cratering stock price.

This leader in digital engagement solutions for the healthcare industry is capitalizing on several secular tailwinds.

Second-quarter adjusted earnings came in at 78 cents a share on revenue of $14.7 billion, beating expectations.

Hims’ second-quarter revenue fell 7% from a quarter ago. The decline goes beyond weakness in its GLP-1 weight-loss business.

These are Berkshire’s first purchases of Sirius XM stock since early February.

Last week’s shooting of four people in Midtown Manhattan comes just seven months after the slaying of UnitedHealth executive Brian Thompson.

The telehealth company fell short of expectations but beat Wall Street’s profit forecast.

Berkshire Hathaway stock fell after second-quarter operating profit after tax fell 4% in the period, while Palantir shares were rising ahead of earnings.

Apple’s iPhone sales jump more than 13% in the tech giant’s fiscal third quarter but the stock trades lower, while Amazon falls on a weaker-than-expected forecast for third-quarter operating income.

The biotech company reported second-quarter financial results on Friday ahead of market open, a day after announcing plans to cut 10% of its staff.

Trump sets a 10% baseline tariff, Apple’s quarter boosted by iPhone sales, Figma stock more than triples in IPO, and more news to start your day.

Microsoft’s market cap briefly surpasses $4 trillion, with the stock getting a lift from cloud revenue that rose 27% in the software giant’s fiscal fourth quarter, while second-quarter revenue at Meta Platforms jumps 22%.

The company boosts its full-year guidance range for adjusted earnings on the heels of a strong second quarter.

The health insurer issued a decent second-quarter financial report that came in slightly ahead of consensus estimates.

The layoffs come as Moderna’s cash position has raised worries on Wall Street that the company may need to raise new capital.

Fed holds rates steady, Microsoft nears $4 trillion valuation, Meta’s earnings blowout, and more news to start your day.